Shares of Stem Inc. surged 10% to $4.29 on September 25 after UBS upgraded the energy storage software company from Neutral to Buy with a $7 price target, implying roughly 63% upside from today's price. The call halted a bruising five-session slide that had dragged the stock down from $4.61 to $3.90, and it forces investors to confront a simple question: is Stem finally turning its software story into real profits? UBS Bets Stem's Software Pivot Can Nearly Double the Stock — But Is a $7 Target Enough to Reward the Risk?

Shares of Stem Inc. jumped 10% to $4.29 on September 25 after UBS upgraded the clean-energy software company from Neutral to Buy with a $7 price target, snapping a five-session losing streak that had pushed the stock from $4.61 to $3.90. The call is a bet that Stem's painful transformation from a hardware reseller into a software-driven business is finally paying off — but with the stock still down sharply from its 52-week high of $32.23, investors must weigh whether the turnaround is real or just a mirage.

  • The Software Engine Is Running, but Revenue Is Shrinking Overall. Q2 2026 revenue fell 12% year-over-year to $33.7 million , a headline number that looks ugly. But the decline is almost entirely because Stem deliberately walked away from low-margin battery hardware sales. Revenue from its core software, services, and edge hardware business rose 1% to $33.4 million, powered by 11% growth in its flagship energy-management software. UBS is betting this higher-quality revenue stream will accelerate. If it doesn't, the upgrade ages poorly.

  • Margins Tell a More Encouraging Story Than Revenue. GAAP gross margin expanded to 38% in Q1 from 32% a year earlier , and hit 41% in Q2, up from 33%.

The company has now posted five straight quarters of positive adjusted EBITDA — a measure of operating profit before certain accounting charges — and software-driven gross margin reached a record 52% in Q1. For a company that lost $854 million in fiscal 2024, that's a meaningful shift.

  • Full-Year Guidance Remains Intact — but the Bar Is Low. Management reaffirmed 2026 targets of $140–$190 million in total revenue, $10–$15 million in adjusted EBITDA, and year-end recurring subscription revenue of $65–$70 million.

Operating cash flow is projected between breakeven and $10 million — barely positive for a company with a market cap under $40 million.

  • A $7 Target Looks Modest Against Wall Street's Wider Range. The broader analyst consensus sits at Hold with an average target of $12.14 , suggesting UBS is actually the cautious bull in the room. Targets range from $6 to $21. The upgrade matters less for its price target than for its signal: a major bank thinks the worst is over. Whether Stem can convert growing software subscriptions into sustainable free cash flow will determine if this stock is a recovery story — or a value trap.